Serum-free suspension system for lentiviral production
AssigneeLife Technologies Corporation
InventorsXin YU, Xavier de MOLLERAT du JEU
Life of this patent
Estimating the term…
Loading patent…
AssigneeLife Technologies Corporation
InventorsXin YU, Xavier de MOLLERAT du JEU
Estimating the term…
A lentiviral vector production system comprises (a) a lentiviral culture supplement to control cell growth, (b) a transfection reagent comprising DHDMS, DOPE, and cholesterol to increase transfection efficiency, (c) a lentiviral production enhancer comprising sodium propionate, sodium butyrate, and caffeine to boost lentiviral production, wherein the lentiviral vector production system is serum-free. A method of lentiviral vector production comprises using the lentiviral production system. Another method for lentiviral vector production comprises (a) culturing eukaryotic cells in a serum-free medium, (b) providing a lentiviral culture supplement to control cell growth, (c) transfecting the cells with a lentiviral vector using a transfection reagent comprising DHDMS, DOPE, and cholesterol to increase transfection efficiency, and (d) providing a lentiviral production using a lentiviral production enhancer comprising sodium propionate, sodium butyrate capable of boosting lentiviral production.
A lentiviral vector production system comprising:
A method for lentiviral vector production comprising;
The method of any one of claims 1-56, wherein the lentiviral culture supplement is added from 24 to 36 hours after cell seeding in cell culture medium.
Dependencies are inferred from the claim text.